SCLERODERMA & RAYNAUD'S UK

Registered charity 1161828 · accounts filings on the Charity Commission register · also known as SCLERODERMA & RAYNAUD?S UK, SRUK

Latest income
£433k
Latest spending
£1.5m
Registered
2015
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that the charity reported a net deficit of £261,004 for the year ended 31 March 2024, driven by increased expenditure on research and infrastructure. Despite this deficit, the charity holds unrestricted reserves of £2,626,871, which the trustees consider adequate and in excess of their stated policy target of approximately £1 million.

What the accounts disclose

Reserves policy: twelve-months’ operating reserve... approximately £1 Million (held: £2.6m)
A policy for maintaining a twelve-months’ operating reserve was retained throughout 2023-24. This amounts to operating reserves of approximately £1 Million. — page 14
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Related party transaction with subsidiary RSA Trading Company Limited
During the year staff recharges of £nil (2023 - £3,031) were made to RSA Trading Company Limited; as at 31 March 2024 SRUK are due £35,681 (2023 - £36,106) from RSA Trading Company Limited. All transactions were carried out at arm’s length. — page 38
Per its FY2024 accounts as filed with the Charity Commission.
Trading subsidiary: RSA Trading Company Limited
The subsidiary was registered in England and Wales with registered number 07869668. A decision has been taken to sell the remaining stock and cease trading. — page 38
Per its FY2024 accounts as filed with the Charity Commission.

Accounts audited by Azets Audit Services.

Public fundraising profile: JustGiving — Scleroderma & Raynaud's UK (SRUK) (matched by registered charity number).

Structured financials (annual return, FY ending 31/03/2024)

Total income
£998k
Total spending
£1.4m
Cost of raising funds
£289k
Reserves (reported)
£2.6m
Employees
11

Reported reserves equal ~22.7 months of spending — in the top quarter for charities its size (median 7.0 months; benchmarks).

Trustees

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025£433k£1.5m
31/03/2024£998k£1.4m
31/03/2023£822k£1.1m
31/03/2022£2.0m£1.1m
31/03/2021£2.3m£1.2m

Common questions

Is SCLERODERMA & RAYNAUD'S UK financially healthy?

The accounts state that the charity reported a net deficit of £261,004 for the year ended 31 March 2024, driven by increased expenditure on research and infrastructure. Despite this deficit, the charity holds unrestricted reserves of £2,626,871, which the trustees consider adequate and in excess of their stated policy target of approximately £1 million. Its FY2024 accounts were audited by Azets Audit Services.

Who funds SCLERODERMA & RAYNAUD'S UK?

Funders whose own accounts filings name SCLERODERMA & RAYNAUD'S UK as a grant recipient include THE ADINT CHARITABLE TRUST, TOM AND SHEILA SPRINGER CHARITY.

Known funders

Grants to this charity found in funders’ own accounts filings.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with BRITISH SOCIETY FOR RHEUMATOLOGY.